Copenhagen, Denmark; February 15, 2007 – Pursuant to
Section 28a of the Danish Securities Trading Act, Genmab A/S (CSE: GEN)
shall make public information on transactions by managerial employees and
their related parties involving Genmab shares and related instruments, as
follows:
|
Name
|
Lisa N. Drakeman
|
|
Reason
|
President, Chief Executive Officer, Board Member
|
|
Issuer
|
Genmab A/S
|
|
ID code/ ISIN
|
DK 0010272202
|
|
Description
|
Shares
|
|
Transaction
|
Sale
|
|
Trading date
|
February 15, 2007
|
|
Market
|
Copenhagen Stock Exchange
|
|
Number
|
150,000
|
|
Market value
|
DKK 53,092,230
|
|
Name
|
Jan G.J. van de Winkel
|
|
Reason
|
Executive Vice President & Chief Scientific Officer
|
|
Issuer
|
Genmab A/S
|
|
ID code/ ISIN
|
DK 0010272202
|
|
Description
|
Shares
|
|
Transaction
|
Sale
|
|
Trading date
|
February 15, 2007
|
|
Market
|
Copenhagen Stock Exchange
|
|
Number
|
110,000
|
|
Market value
|
DKK 38,934,302
|
|
Name
|
Claus Juan Møller-San Pedro
|
|
Reason
|
Executive Vice President & Chief Operating Officer
|
|
Issuer
|
Genmab A/S
|
|
ID code/ ISIN
|
DK 0010272202
|
|
Description
|
Shares
|
|
Transaction
|
Sale
|
|
Trading date
|
February 15, 2007
|
|
Market
|
Copenhagen Stock Exchange
|
|
Number
|
120,000
|
|
Market value
|
DKK 42,473,784
|
|
Name
|
Bo Kruse
|
|
Reason
|
Vice President, Chief Financial Officer
|
|
Issuer
|
Genmab A/S
|
|
ID code/ ISIN
|
DK 0010272202
|
|
Description
|
Shares
|
|
Transaction
|
Sale
|
|
Trading date
|
February 15, 2007
|
|
Market
|
Copenhagen Stock Exchange
|
|
Number
|
20,000
|
|
Market value
|
DKK 7,078,964
|